PNC Financial Services Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Buy |
8,828
+820
| +10% | +$11.5K | ﹤0.01% | 2558 |
|
|
2025
Q1 | $125K | Sell |
8,008
-263
| -3% | -$4.11K | ﹤0.01% | 2515 |
|
|
2024
Q4 | $115K | Sell |
8,271
-1,648
| -17% | -$23K | ﹤0.01% | 2597 |
|
|
2024
Q3 | $92.2K | Buy |
9,919
+188
| +2% | +$1.75K | ﹤0.01% | 2714 |
|
|
2024
Q2 | $90.5K | Sell |
9,731
-33
| -0.3% | -$307 | ﹤0.01% | 2694 |
|
|
2024
Q1 | $96.8K | Buy |
9,764
+241
| +3% | +$2.39K | ﹤0.01% | 2633 |
|
|
2023
Q4 | $30.8K | Buy |
9,523
+539
| +6% | +$1.74K | ﹤0.01% | 3210 |
|
|
2023
Q3 | $47.7K | Sell |
8,984
-831
| -8% | -$4.41K | ﹤0.01% | 2984 |
|
|
2023
Q2 | $93.5K | Buy |
9,815
+1,598
| +19% | +$15.2K | ﹤0.01% | 2682 |
|
|
2023
Q1 | $90.4K | Sell |
8,217
-5,763
| -41% | -$63.4K | ﹤0.01% | 2625 |
|
|
2022
Q4 | $207K | Buy |
13,980
+4,415
| +46% | +$65.3K | ﹤0.01% | 2102 |
|
|
2022
Q3 | $183K | Buy |
9,565
+6,917
| +261% | +$132K | ﹤0.01% | 2146 |
|
|
2022
Q2 | $56K | Buy |
+2,648
| New | +$56K | ﹤0.01% | 2916 |
|
|
2021
Q4 | – | Sell |
-1,500
| Closed | -$36K | – | 4436 |
|
|
2021
Q3 | $36K | Hold |
1,500
| – | – | ﹤0.01% | 3246 |
|
|
2021
Q2 | $40K | Buy |
+1,500
| New | +$40K | ﹤0.01% | 3181 |
|